HYPERFINE INC CLASS A (HYPR)
Health Care · Medical imaging equipment / portable MRI systems · NASDAQ
Hyperfine makes AI-powered portable ultra-low-field MRI systems designed to bring affordable brain imaging to hospitals and clinics anywhere, without specialized facilities or technicians.
What HYPERFINE INC CLASS A does
Hyperfine is a health technology company that manufactures and sells the Swoop® portable ultra-low-field (ULF) MRI system for brain imaging. The AI-powered Swoop system produces high-quality brain MR images at significantly lower magnetic field strength than conventional MRI scanners, enabling diagnosis and monitoring of neurological conditions in diverse care settings without requiring special facilities or specialized personnel. The company's portable device is designed to increase access to brain MRI imaging in a cost-effective manner across hospitals, clinics, emergency departments, ICUs, and physician offices.
Themes: portable MRI imaging, ultra-low-field (ULF) MRI, AI-powered medical imaging, brain imaging diagnostics, decentralized healthcare / point-of-care imaging, neurological imaging
Fundamentals
- Price$0.902 as of 2026-08-21 close
- Market cap$95M as of 2026-08-24
- 1-year return-26.7% 2025-08-21 close $1.23 → 2026-08-21 close $0.902
- P/En/a negative earnings
- Net margin-226.9% as of 2026-08-24
- Gross margin+51.2% as of 2026-08-24
- ROE-101.3% as of 2026-08-24
- Debt / equity0.38 as of 2026-08-24
- Revenue growth (YoY)+30.7% as of 2026-08-24
- Revenue CAGR (3y)+25.8% SEC XBRL
- Beta1.48 as of 2026-08-24
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How HYPR compares in its sector
- net profit marginbottom 25% 504 covered Health Care peers, as of 2026-08-24
- operating marginbottom 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitybottom 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How HYPERFINE INC CLASS A looks technically
HYPERFINE INC CLASS A (HYPR) is trading 23.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 7 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 18 trading days ago. It is 59.4% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 23.7% below its 200-day average, the long-term trend line — a long-term downtrend | -23.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $1.12 | $1.12 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $1.18 | $1.18 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 17 calendar days ago — the swings before that are what the structure reading is measured on | 17 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five; the labelling fails if price closes above 1.05. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 5 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 7 trading days ago — a "death cross", a bearish long-term signal | 7 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend) | 20.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30) | 36.0 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($0.865 to $1.05) — its "stochastic" reading is 20 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 20.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 17 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $2.22 | $2.22 |
|---|---|---|
| From the 52-week high | it is 59.4% below its 52-week high (its highest price of the past year) | -59.4% |
| Above the 52-week low | it is 6.1% above its 52-week low (its lowest price of the past year) | +6.1% |
| Below the 52-week high | it is 59.4% below its highest point of the past year | 59.4% |
| Since a 20-day breakout | it made a new 20-day low about 18 trading days ago | 18 sessions |
| Since a 55-day breakout | it made a new 55-day low about 18 trading days ago | 18 sessions |
| All-time high | its highest closing price on record is $11.99 (set on 2021-12-27) | $11.99 |
| Given back of the 52-week move | over the past year its closes ranged ($0.891 to $2.20), and it has recovered essentially none of its fall from last year’s high — 1% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $1.70 to $1.74. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.8% |
| From the all-time high | it is 92.5% below its all-time high | -92.5% |
| Nearest price level | it is trading 1.3% below a resistance level at $0.9133 — a price it turned at three times since 2025-01-21, most recently on 2026-07-17. Since 2024-08-21 it has 5 such levels below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.3% |
| All-time low | its lowest closing price on record is $0.5327 (set on 2025-05-23) | $0.5327 |
| Above the all-time low | it is 69.3% above its all-time low | +69.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 82% of it) | 18th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.0651 between its high and its low — about 7.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.0651 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $0.86 and $1.01 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $0.86 – $0.93 – $1.01 |
| Typical daily range (% of price) | its price moves about 7.2% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 7.2% |
| Stretch from the 200-day average | it is trading 4.3 daily ranges below its 200-day average price (23.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.76× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|---|---|
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 1.8% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +1.8% |
|---|---|---|
| Open gap | it gapped 3.5% below the previous close 37 sessions ago and has not traded back through the level it left behind at 1.44 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -3.5% |
| Gap filled | a 2.2% gap up opened on 2026-07-02 has been "filled" 35 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 35 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 11.3 percentage points (the stock lost 9.0% while the market gained 2.3%) | -11.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 43.0 percentage points (the stock lost 39.9% while the market gained 3.1%) | -43.0% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 32.6 percentage points (the stock lost 21.6% while the market gained 11.1%) | -32.6% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 47.1 percentage points (the stock lost 26.7% while the market gained 20.5%) | -47.1% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: MACD momentum is positive, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 26% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 23.6% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -26.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 30% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $1.30 — a volume-weighted average of daily closes over 155 sessions, not a true tick-by-tick VWAP. | -30.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% below the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is under water. That average is $0.9177 — a volume-weighted average of daily closes over 12 sessions, not a true tick-by-tick VWAP. | -1.7% |
Price levels it has turned at before
HYPR last closed at $0.902 on 2026-08-21. Since 2024-08-21 it has turned at 5 prices below its last close and 9 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $0.9133 | Resistance | 1.3% above the last close | turned there three times · 2025-01-21 to 2026-07-17 |
| $0.8745 | Support | 3.0% below the last close | turned there twice · 2025-12-31 to 2026-07-29 |
| $0.8506 | Support | 5.7% below the last close | turned there four times · 2024-09-05 to 2025-12-03 |
| $0.9649 | Resistance | 7.0% above the last close | turned there three times · 2024-09-18 to 2024-10-15 |
| $0.825 | Support | 8.5% below the last close | turned there twice · 2024-11-15 to 2025-07-07 |
| $1.03 | Resistance | 14.1% above the last close | turned there six times · 2024-11-25 to 2026-03-30 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five.
This labelling fails — stops being a possible reading at all — if it closes above $1.05.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $0.1358 and $0.7008 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Recent death cross (50-day crossed below 200-day) · Pulled back from the 12-month high · lagging the market · Most volatile (6%+ typical daily range) · At the bottom of its 14-day range (stochastic below 20) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.00 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
- Mean price target$2.03 range $1.60 – $2.50; median $2.00
Analyst estimates, as of 2026-08-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HYPR
- Consensus EPS estimate-$0.08 next reporting period, as of 2026-08-21
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Company has history of significant losses and unprofitable operations; substantial doubt regarding ability to continue as a going concern","Faces intense competition from established MRI manufacturers with greater financial and marketing resources","Dependent on regulatory approvals (FDA 510(k) clearance) and reimbursement decisions by payers for clinical adoption and revenue growth"]
What changed in the latest 10-Q
AI-assisted comparison of HYPR's 10-Q filed 2026-05-12 against the prior one filed 2025-11-13.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing references 2025 Annual Report on Form 10-K (filed 2026-05-12), older filing references 2024 Annual Report on Form 10-K (filed 2025-11-13)
- Newer filing covers three months ended March 31, 2026 and 2025; older filing covers three and nine months ended September 30, 2025 and 2024
- Newer filing describes Swoop system as producing images at 'significantly lower magnetic field strength' vs. older filing's 'lower magnetic field strength'
- Newer filing specifies 'iPad-based interface' for operation; older filing references 'easy-to-use interface' without specifying iPad
- Newer filing states system 'does not require specialized MRI technicians to operate safely'; older filing states it 'does not require any special facilities accommodations nor specialized personnel to operate safely'
- Newer filing includes reference to 'Optive AI TM' as a specific form of AI in denoising and reconstruction pipeline with trademark notation
- Newer filing explicitly names 'Optive AI TM' models as proprietary and validated by expert radiologists
- Newer filing states 'eleven generations of software since our initial clearance'; older filing states 'ten generations of software since our initial clearance'
- Newer filing adds language about 'continuously investing in improving our AI-powered image quality and leveraging each imaging-focused software release to further improve the Swoop® system performance and clinical utility'; older filing omits 'and clinical utility'
- Newer filing describes tenth-generation software as producing images 'with greater clarity, uniformity and sharper anatomical detail'; older filing states 'and the result is brain images with greater clarity, uniformity and sharper anatomical detail'
- Newer filing states next-generation system 'incorporates innovations specifically engineered'; older filing states it 'features innovations specifically engineered'
- Newer filing text cuts off at 'In December 2025' suggesting additional content; older filing includes discussion of CE Mark and UKCA Mark approvals in October 2024 and February 2025
- Removed:
- Older filing includes references to Risk Factors sections in 2024 Form 10-K and Quarterly Reports for quarters ended March 31, 2025 and June 30, 2025; newer filing only references 2025 Form 10-K
- Older filing references 'installed base' language; newer filing uses 'installed base' in similar context but with different surrounding phrasing
- Older filing discusses marketing authorization outside United States including CE Mark and UKCA Mark approvals in October 2024 and February 2025; this content is cut off in newer filing
- Reworded:
- Older: 'enabling a highly differentiated experience for patients' changed to newer: 'enabling a highly differentiated patient-friendly experience'
- Older: 'favorable economics for hospital administrators' changed to newer: 'favorable economics for healthcare administrators'
- Older: 'intensive care units, clinics, emergency departments or physicians' offices' changed to newer: 'intensive care units, emergency departments, procedural rooms, clinics or physicians' offices' (addition of 'procedural rooms')
- Older: 'specialized operators' changed to newer: 'specialized technicians'
- Older: 'address the limitations of conventional imaging technologies' changed to newer: 'address the limitations of conventional MRI technologies'
- Older: 'accessible nearly anytime and anywhere' changed to newer: 'accessible nearly anywhere'
- Older: 'has the potential to offer clinical and economic benefits' changed to newer: 'has potential clinical and economic benefits'
- Older: 'a form of AI in the reconstruction pipeline of T1, T2, diffusion-weighted Imaging, and fluid-attenuated inversion recovery sequences' changed to newer: 'Optive AI TM, a form of AI in the denoising and reconstruction pipeline of the sequences'
- Older: 'The algorithms are designed to improve' changed to newer: 'Our proprietary Optive AI TM models are designed to improve'
- Older: 'The images created with these algorithms were validated by expert radiologists' changed to newer: 'The Optive AI TM models are validated by expert radiologists'
- Older: 'install base continues to expand' changed to newer: 'installed base continues to expand globally'
- Older: 'further improve the Swoop® system performance' changed to newer: 'further improve the Swoop® system performance and clinical utility'
- Older: 'A very important milestone for us was obtaining' changed to newer: 'Obtaining...was a very important milestone for us'
- Notes:
- The newer filing text appears truncated at 'In December 2025' making complete comparison of subsequent sections impossible
- Both filings discuss the same product and basic business model but cover different fiscal periods (Q1 2026 vs. Q3 2025)
Risk Factors
- Added:
- Reference to Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed March 18, 2026 (newer filing, filed 2026-05-12)
- Long-term debt, net of $13,123 thousand as of March 31, 2026 (newer filing, filed 2026-05-12)
- Removed:
- References to Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed March 17, 2025 (older filing, filed 2025-11-13)
- Reference to Quarterly Report on Form 10-Q for quarter ended March 31, 2025, filed May 13, 2025 (older filing, filed 2025-11-13)
- Reference to Quarterly Report on Form 10-Q for quarter ended June 30, 2025, filed August 13, 2025 (older filing, filed 2025-11-13)
- Warrant liabilities of $3,497 thousand as of September 30, 2025 (older filing, filed 2025-11-13)
- Reworded:
- Forward-looking statements reference changed from 'anticipated National Institutes of Health funding pressures' to 'National Institutes of Health funding pressures' (removed 'anticipated') (newer filing, filed 2026-05-12)
- Forward-looking statements reference changed from 'the expected effect from U.S. export controls and tariffs' to 'the effect from U.S. export controls and tariffs' (removed 'expected') (newer filing, filed 2026-05-12)
- Reference to prior SEC filings condensed from multiple specific filings to single consolidated reference to '2025 Annual Report on Form 10-K' and 'subsequent filings' (newer filing, filed 2026-05-12)
- Cautionary statement attribution changed from 'persons acting on its behalf' to 'persons acting on the Company's behalf' (newer filing, filed 2026-05-12)
- Notes:
- The texts provided include table of contents page numbers and balance sheet data; the Risk Factors section itself (Item 1A) is referenced but the detailed risk factor disclosures are not included in either excerpt
- Balance sheet comparison dates differ (March 31, 2026 vs. September 30, 2025), making direct asset/liability comparisons not fully aligned across the same time periods
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 4 sells ($78490) — 2 selling insiders
Most recent open-market transaction: 2026-05-26. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HYPR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding HYPR as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 1,643,706
- Reported value $1,775,203
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
HYPR had 2,955,093 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for HYPR because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 2,955,093
- Prior settlement (shares) 2,568,688
- Reported change 15.04%
- Days to cover (reported) 3.75
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HYPR vs…
Frequently asked questions
What does HYPERFINE INC CLASS A (HYPR) do?
Hyperfine is a health technology company that manufactures and sells the Swoop® portable ultra-low-field (ULF) MRI system for brain imaging. The AI-powered Swoop system produces high-quality brain MR images at significantly lower magnetic field strength than conventional MRI scanners, enabling diagnosis and monitoring of neurological conditions in diverse care settings without requiring special facilities or specialized personnel.
What sector is HYPERFINE INC CLASS A (HYPR) in?
HYPERFINE INC CLASS A (HYPR) is classified in the Health Care sector. Its industry is Medical imaging equipment / portable MRI systems. It trades on NASDAQ.
Who are HYPERFINE INC CLASS A's (HYPR) competitors?
Notable peers of HYPERFINE INC CLASS A (HYPR) include GE Healthcare, Siemens Healthineers, Philips Healthcare and Canon Medical Systems. This peer set is informational only — not financial advice.
Is HYPERFINE INC CLASS A (HYPR) overbought or oversold right now?
HYPERFINE INC CLASS A (HYPR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 36, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HYPR come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.